Vassiliki Economides - Net Worth and Insider Trading

Vassiliki Economides Net Worth

The estimated net worth of Vassiliki Economides is at least $180,208 dollars as of 2024-04-29. Vassiliki Economides is the See Remarks of Gritstone Bio Inc and owns about 214,058 shares of Gritstone Bio Inc (GRTS) stock worth over $174,115. Vassiliki Economides is also the SVP, Strategy & External Aff. of Kezar Life Sciences Inc and owns about 7,570 shares of Kezar Life Sciences Inc (KZR) stock worth over $6,093. Details can be seen in Vassiliki Economides's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Vassiliki Economides has not made any transactions after 2023-05-23 and currently still holds the listed stock(s).

Transaction Summary of Vassiliki Economides

To

Vassiliki Economides Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Vassiliki Economides owns 2 companies in total, including Kezar Life Sciences Inc (KZR) , and Gritstone Bio Inc (GRTS) .

Click here to see the complete history of Vassiliki Economides’s form 4 insider trades.

Insider Ownership Summary of Vassiliki Economides

Ticker Comapny Transaction Date Type of Owner
KZR Kezar Life Sciences Inc 2020-02-04 SVP & Strategy & External Aff.
GRTS Gritstone Bio Inc 2023-05-23 See Remarks

Vassiliki Economides Latest Holdings Summary

Vassiliki Economides currently owns a total of 2 stocks. Among these stocks, Vassiliki Economides owns 214,058 shares of Gritstone Bio Inc (GRTS) as of May 23, 2023, with a value of $174,115 and a weighting of 96.62%. Vassiliki Economides also owns 7,570 shares of Kezar Life Sciences Inc (KZR) as of February 4, 2020, with a value of $6,093 and a weighting of 3.38%.

Latest Holdings of Vassiliki Economides

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GRTS Gritstone Bio Inc 2023-05-23 214,058 0.81 174,115
KZR Kezar Life Sciences Inc 2020-02-04 7,570 0.80 6,093

Holding Weightings of Vassiliki Economides


Vassiliki Economides Form 4 Trading Tracker

According to the SEC Form 4 filings, Vassiliki Economides has made a total of 1 transactions in Gritstone Bio Inc (GRTS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Gritstone Bio Inc is the acquisition of 12,000 shares on May 23, 2023, which cost Vassiliki Economides around $22,800.

According to the SEC Form 4 filings, Vassiliki Economides has made a total of 5 transactions in Kezar Life Sciences Inc (KZR) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Kezar Life Sciences Inc is the acquisition of 5,769 shares on February 4, 2020, which cost Vassiliki Economides around $14,999.

Insider Trading History of Vassiliki Economides

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Vassiliki Economides Trading Performance

GuruFocus tracks the stock performance after each of Vassiliki Economides's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vassiliki Economides is -21.32%. GuruFocus also compares Vassiliki Economides's trading performance to market benchmark return within the same time period. The performance of stocks bought by Vassiliki Economides within 3 months outperforms 1 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Vassiliki Economides's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Vassiliki Economides

Average Return

2.53%

Average return per transaction

Outperforming Transactions

40%

2 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.57 -21.32 -14.54 2.53 19.39 18.3
Relative Return to S&P 500(%) -0.84 -23.27 -25.27 -11.02 -2.1 6.79

Vassiliki Economides Ownership Network

Ownership Network List of Vassiliki Economides

No Data

Ownership Network Relation of Vassiliki Economides


Vassiliki Economides Owned Company Details

What does Kezar Life Sciences Inc do?

Who are the key executives at Kezar Life Sciences Inc?

Vassiliki Economides is the SVP & Strategy & External Aff. of Kezar Life Sciences Inc. Other key executives at Kezar Life Sciences Inc include 10 percent owner Morningside Venture Investments Ltd , Chief Business Officer Nicholas Michael Mordwinkin , and 10 percent owner Equal Talent Investments Ltd .

Kezar Life Sciences Inc (KZR) Insider Trades Summary

Over the past 18 months, Vassiliki Economides made no insider transaction in Kezar Life Sciences Inc (KZR). Other recent insider transactions involving Kezar Life Sciences Inc (KZR) include a net sale of 508,747 shares made by Morningside Venture Investments Ltd ,

In summary, during the past 3 months, insiders sold 0 shares of Kezar Life Sciences Inc (KZR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 508,747 shares of Kezar Life Sciences Inc (KZR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 508,747 shares.

Kezar Life Sciences Inc (KZR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kezar Life Sciences Inc Insider Transactions

No Available Data

Vassiliki Economides Mailing Address

Above is the net worth, insider trading, and ownership report for Vassiliki Economides. You might contact Vassiliki Economides via mailing address: C/o Kezar Life Sciences, Inc., 4000 Shoreline Court, Suite 300, South San Francisco Ca 94080.

Discussions on Vassiliki Economides

No discussions yet.